Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MITF | O75030 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | STAT6 | P42226 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5421438 | 0.98 | SMN1; SMN2 (0.50) | SMN1; SMN2MITFLMNAHPGDMAPT | |
| SCHEMBL31551856 | 0.98 | SMN1; SMN2 (0.50) | SMN1; SMN2MITFLMNAHPGDMAPT | |
| SCHEMBL205421 | 0.95 | LMNA (0.48) | SMN1; SMN2MITFLMNAHPGDMAPT | |
| SCHEMBL7495565 | 0.93 | LMNA (0.47) | SMN1; SMN2MITFLMNAHPGDMAPT | |
| SCHEMBL513188 | 0.87 | USP2 (0.43) | SMN1; SMN2HPGDMAPTKDM4ETHRB | |
| Formic Acid Methyl Ester SCHEMBL27092786 | 0.85 | MAPT (0.41) | SMN1; SMN2MITFLMNAHPGDMAPT | |
| SCHEMBL22578666 | 0.84 | CHRM2 (0.37) | SMN1; SMN2MITFLMNAHPGDMAPT | |
| SCHEMBL17043059 | 0.83 | MITF (0.43) | SMN1; SMN2MITFLMNAMAPTMEN1 | |
| SCHEMBL28974037 | 0.83 | LMNA (0.41) | SMN1; SMN2LMNAHPGDMAPTMEN1 | |
| SCHEMBL5278772 | 0.81 | HPGD (0.40) | SMN1; SMN2MITFHPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 759 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119661529-A | Synthesis method of 3, 9-diazaspiro [5.5] undecane-3-tert-butyl formate | 上海馨远医药科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-117658896-A | Curcumin-piperlongumin derivative and preparation method and application thereof | 温州医科大学 | 2024-03-08 | — | — | CN | claimed |
| CN-114277006-B | Alcohol dehydrogenase and application thereof in synthesis of chiral heterocyclic alcohol | 江南大学 | 2023-06-06 | — | — | CN | claimed |
| CN-114277006-A | Alcohol dehydrogenase and application thereof in synthesis of chiral heterocyclic alcohol | 江南大学 | 2022-04-05 | — | — | CN | claimed |
| CN-111116456-B | Preparation method of 4, 4-difluoropiperidine hydrochloride | 南通华祥医药科技有限公司 | 2022-01-28 | — | — | CN | claimed |
| US-20180326407-A1 | Olefin polymerization catalyst components and process for the production of olefin polymers therewith | FORMOSA PLASTICS CORPORATION, USA | 2018-11-15 | — | — | US | claimed |
| US-10124324-B1 | Olefin polymerization catalyst components and process for the production of olefin polymers therewith | FORMOSA PLASTICS CORPORATION, USA (US) | 2018-11-13 | — | — | US | claimed |
| WO-2026098613-A1 | METHOD FOR PREPARING BENZODIOXOLE OR SALT THEREOF | 江苏恒瑞医药股份有限公司 | 2026-05-15 | — | — | WO | disclosed |
| EP-4731623-A1 | CARBOLINE COMPOUNDS AND USE THEREOF | PTC Therapeutics, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4727915-A1 | AMIDE CONTAINING LIPIDS | Acuitas Therapeutics, Inc. (CA) | 2026-04-22 | — | — | EP | disclosed |
| US-12605450-B2 | C3-carbon linked glutarimide Degronimers for target protein degradation | C4 THERAPEUTICS, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-12589092-B2 | Polycyclic compound acting as kinase inhibitor | HANGZHOU INNOGATE PHARMA CO., LTD. (CN) | 2026-03-31 | — | — | US | disclosed |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-6037341-A | HAVING POTENT ANTIMICROBIAL EFFECTS OVER GRAM-POSITIVE BACTERIA AND GRAM-NEGATIVE BACTERIA | EISAI CO., LTD. (JP) | 2000-03-14 | — | — | US | disclosed |
| US-5998438-A | SEROTONIN RECEPTOR ANTAGONIST; HEADACHE THERAPY | ALLELIX BIOPHARMACEUTICALS, INC. (CA) | 1999-12-07 | — | — | US | disclosed |
| EP-0940401-A1 | 2-CARBONYLTHIAZOLE DERIVATIVES AND USE OF THE SAME | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1999-09-08 | — | — | EP | disclosed |
| US-5852049-A | Aromatic ethers derived from indoles which are useful as medicaments | PIERRE FABRE MEDICAMENT (FR) | 1998-12-22 | — | — | US | disclosed |
| US-5734059-A | Production intermediate and process for producing pyridine derivative | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1998-03-31 | — | — | US | disclosed |
| EP-0787724-A1 | NOVEL INTERMEDIATE FOR PRODUCTION AND PROCESS FOR PRODUCING PYRIDINE DERIVATIVE | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1997-08-06 | — | — | EP | disclosed |
| EP-0773222-A1 | NOVEL CARBAPENEM DERIVATIVE | Eisai Co., Ltd. (JP) | 1997-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605450-B2 | C3-carbon linked glutarimide Degronimers for target protein degradation | NEDD4, UBE3A, UBE3C | SMN1; SMN2 3245/4885MITF 4077/4885LMNA 2573/4885 |
| US-12589092-B2 | Polycyclic compound acting as kinase inhibitor | CDK1, CDK4, CDK2 | SMN1; SMN2 2735/4885MITF 1997/4885LMNA 1602/4885 |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | NR3C2, ADRA1A, CNR1 | SMN1; SMN2 1645/4885MITF 2355/4885LMNA 1465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.